InnovAge Holding Corp

InnovAge Holding Corp(INNV)股票分析

$9.520

+0.396 (+4.16%)收盤時

Loading chart…
最高
9.530
開盤
9.100
成交量加權均價
9.38
成交量
950.83K
市值
712.58M
最低
9.090
成交金額
8.92M
企業價值/稅息折舊攤銷前利潤(TTM)
15.53

InnovAge Holding Corp. is a healthcare delivery platform. The Company is engaged in managing the care of high-cost, frail, and dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). Its programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its PACE program, it offers a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center, and third-party medical appointments and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who oversee all aspects of each participant’s care plan.

AI 分析 of InnovAge Holding Corp (INNV)

持有

InnovAge Holding Corp is currently trading at $8.85, which is below the analyst price target of $14, indicating potential upside. However, the stock has a low RSI of 28.335, suggesting it may be oversold, but recent insider selling has increased by 105.94%, which raises concerns about market confidence. The forward P/E ratio is 13.66, which is reasonable, but the recent secondary offering at $9.25 may dilute existing shares and negatively impact the stock price in the short term.

估值指標

InnovAge Holding Corp(INNV)目前預期本益比為 13.66,5 年平均預期本益比為 -108.37。

預期本益比

合理
5 年均值 P/E
-108.37
目前P/E
13.66
高估
969.20
低估
-1185.93

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-7.91
目前EV/EBITDA
15.53
高估
181.49
低估
-197.31

預期股價營收比

合理
5 年均值 P/S
0.98
目前P/S
1.08
高估
1.27
低估
0.69

Alphio AI 對 INNV 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%INNV

$4.78

情境價格

基

基準

基準 · 50%INNV

$4.75

情境價格

悲

悲觀

悲觀 · 25%INNV

$3.97

情境價格

持有 INNV 的大戶

C

Coliseum Capital Management, LLC

+ 持有INNV

-27.11%

3個月報酬率

事件時間軸

2026-09-23 (ET)

16:30:00

Major Averages Close Lower as 10-Year Treasury Yield Hits 5.13%

12:00:00

Major Averages Broadly Lower as Oil Rises Over 1%

2026-09-22 (ET)

22:00:00

Barclays, Goldman Sachs, and Wells Fargo Jointly Manage Offering Priced at $9.25

20:00:00

Dow Falls, Nasdaq Hits New Record Highs

17:00:00

Barclays, Goldman Sachs, and Wells Fargo Jointly Manage Offering

資訊

INNV 常見問題 —— 由 Alphio AI 解答

InnovAge Holding Corp. is a healthcare delivery platform. The Company is engaged in managing the care of high-cost, frail, and dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). Its programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its PACE program, it offers a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center, and third-party medical appointments and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who oversee all aspects of each participant’s care plan. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

InnovAge Holding Corp is currently trading at $8.85, which is below the analyst price target of $14, indicating potential upside. However, the stock has a low RSI of 28.335, suggesting it may be oversold, but recent insider selling has increased by 105.94%, which raises concerns about market confidence. The forward P/E ratio is 13.66, which is reasonable, but the recent secondary offering at $9.25 may dilute existing shares and negatively impact the stock price in the short term.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易